UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in GILD — Gilead Sciences, Inc.
CIK 861177
NEW YORK, NY
Position in GILD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,839,558,979
+$243,839,075 QoQ
Shares Held
13,199,103
+1.5% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 58.09662974824881.ToString("F0")%
Shared 0.ToString("F0")%
None 41.9033702517512.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $23,080,171,805 across 16 Drug Manufacturers - General names. GILD ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,072,021 | $6,504,632,749 | |
| 2 | JNJ |
Johnson & Johnson
|
19,628,113 | $4,797,895,938 | |
| 3 | ABBV |
AbbVie Inc.
|
14,161,606 | $3,080,007,683 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,414,819 | $2,455,698,571 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
13,199,103 | $1,839,558,979 | |
| 6 | AMGN |
Amgen Inc
|
4,784,982 | $1,683,595,911 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
22,719,320 | $1,377,926,752 | |
| 8 | PFE |
Pfizer Inc
|
34,522,932 | $969,403,925 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,839,558,979 | 13,199,103 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,595,719,904 | 13,000,814 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,441,725,165 | 12,988,515 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,838,565,852 | 16,583,078 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,541,301,638 | 13,755,481 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $1,130,116,646 | 12,234,672 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $891,130,489 | 10,628,942 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $764,299,953 | 11,139,775 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $697,694,599 | 9,524,841 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $765,222,478 | 9,446,025 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $701,128,215 | 9,355,861 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $686,304,720 | 8,904,953 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $738,843,946 | 8,904,953 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $804,705,096 | 9,373,385 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $608,357,720 | 9,861,529 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $569,601,579 | 9,215,363 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $700,852,654 | 11,788,943 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $672,454,999 | 9,261,190 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $623,546,403 | 8,926,935 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $597,880,663 | 8,682,554 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $585,580,367 | 9,060,504 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $524,168,303 | 8,997,053 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $543,699,016 | 8,604,194 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $635,153,930 | 8,255,185 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $507,174,452 | 6,784,035 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||